7 results · 28ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

HYPHEN BioMed

Manufacturer
🇫🇷 France

HYPHEN BIOMED SASU

FDA registration
HYPHEN BIOMED SASU·10 products·🇫🇷 France

ZYMUTEST HIA IgGAM; REF Number: RK040D; UDI: 03663537018770 a qualitative screening assay intended for the global detection of heparin- dependent antibodies, whether the isotype is: IgG, IgM and IgA, in human plasma, by clinical laboratories.

FDA Enforcement
Class II ·Terminated·Hyphen BioMed·May 16, 2018

ZYMUTEST HIA MonoStria qualitative screening assay intended for the global detection of heparin-dependent antibodies, whether the isotype is: IgG, IgM and IgA, in human plasma, by clinical laboratories. p IgGAM; REF Number: RK041D; UDI: 03663537046810

FDA Enforcement
Class II ·Terminated·Hyphen BioMed·May 16, 2018

ZYMUTEST HIA IgGAM. Model Number: RK040D. Qualitative screening assay for the detection of heparin-dependent antibodies (IgG, IgM and IgA isotypes by ELISA. 96 Tests.

FDA Enforcement
Class II ·Terminated·Hyphen BioMed·March 21, 2018

ZYMUTEST HIA MonoStrip IgGAM. Model Number: RK041D. Qualitative screening assay for the detection of heparin-dependent antibodies (IgG, IgM and IgA isotypes by ELISA. 32 Tests.

FDA Enforcement
Class II ·Terminated·Hyphen BioMed·March 21, 2018

ZYMUTEST HIA MonoStrip IgG; REF Number: RK041A; UDI: 03663537046803 a qualitative assay intended for the detection of heparin-dependent antibodies of the IgG isotype, in human plasma, by clinical laboratories. It is intended for in vitro diagnostic use.

FDA Enforcement
Class II ·Terminated·Hyphen BioMed·May 16, 2018